Drug recall D-0996-2019
Product
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Reason for recall
Failed Dissolution Specifications
Lots and codes
Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021
Recall details
- Recalling firm
- Lannett Company Inc., Seymour, IN
- Quantity
- 14,448 bottles
- Distribution
- Nationwide, including Puerto Rico.
- Type
- N/A
- Recall initiated
- February 21, 2019
- Terminated
- November 6, 2020
Related products
- Oxybutynin Chloride – drug information
- NDC 62175-272 Oxybutynin Chloride Extended Release · Oxybutynin Chloride 15 mg/1 · Lannett Company, Inc.
- NDC 62175-270 Oxybutynin Chloride Extended Release · Oxybutynin Chloride 5 mg/1 · Lannett Company, Inc.
- NDC 62175-271 Oxybutynin Chloride Extended Release · Oxybutynin Chloride 10 mg/1 · Lannett Company, Inc.